NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$21.50 USD
-0.65 (-2.93%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $21.51 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Brokerage Reports
NovoCure Limited [NVCR]
Reports for Purchase
Showing records 101 - 120 ( 211 total )
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
COVID-19 Impact on Coverage Universe: Week of March 30 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
COVID-19 Impact on Coverage Universe: Week of March 30 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
From Underneath The Rubble Sing a Rebel Song
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
4Q19 Financials; Interim LUNAR Data May Illuminate 2H20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Preliminary Q4:19: Slowing GBM Script Growth, but Increasing Rev per Patient
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Biotechnology - SITC 2019 Abstract Title Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: NovoCure Limited
Industry: Medical Services
3Q19; Novocure Story Unchanged for Us, Awaiting LUNAR 2H20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: NovoCure Limited
Industry: Medical Services
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: NovoCure Limited
Industry: Medical Services
FDA Approval of TTFs for Mesothelioma Expands Cancer Tech Beyond Headwear
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Biotechnology- ASCO Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.